BRAF WASFL-BRAF Fusion Detail (hg38) (BRAF)

Information

Genome

Assembly Position
hg19 chr7:140,419,127-140,624,729 View the variant detail on this assembly version.
 
hg38 chr7:140,719,327-140,924,929
 
Summary

MGeND

Clinical significance
Variant entry
GWAS entry
Disease area statistics Show details

ClinVar

Clinical Significance
Review star [No Data.]
Show details
Links
Type Database ID Link
Gene MIM 164757 OMIM
HGNC 1097 HGNC
Ensembl ENSG00000157764 Ensembl
NCBI NCBI
Gene Cards Gene Cards
OncoKB OncoKB
Type Database ID Link
Variant TogoVar
COSMIC
MONDO
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
Disease Drug EL ET ED CS VO TR Pubmed Links
cancer Vemurafenib C Predictive Does Not Support Sensitivity/Response Somatic 2 29320312 Detail
DisGeNET
[No Data.]
Annotation

Annotations

DescrptionSourceLinks
The phase 2a MyPathway study assigned patients with HER2, EGFR, BRAF or SHH alterations to treatment... CIViC Evidence Detail
Gene
BRAF
Genome
hg38
Position
chr7:140,719,327-140,924,929
Variant Type
fusion
Variant (CIViC) (CIViC Variant)
WASFL-BRAF Fusion
Variant URL (CIViC Variant)
https://civic.genome.wustl.edu/links/variants/2228
Variant (CIViC) (CIViC Variant)
FAM73A-BRAF fusion
Variant URL (CIViC Variant)
https://civic.genome.wustl.edu/links/variants/2987
Genome browser